Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IRCCS Ospedale Galeazzi-Sant'Ambrogio is a premier Italian research hospital and a center of excellence for musculoskeletal and cardiovascular health, located in the Milan Innovation District (MIND). Formed by the merger of the Galeazzi Orthopedic Institute and the Sant'Ambrogio Clinical Institute, it is recognized by the Italian Ministry of Health as a Scientific Institute for Research, Hospitalization and Health Care (IRCCS). The facility is a leader in orthopedic surgery, neurosurgery, and cardiovascular treatments, integrating high-level clinical care with advanced translational research. It serves as a major hub for regenerative medicine, particularly in the development of cell-based therapies for bone and cartilage repair. As part of Gruppo San Donato, it represents one of the most technologically advanced hospital structures in Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IRCCS Ospedale Galeazzi-Sant'Ambrogio.